Literature DB >> 2462305

Molecular characterization of a prominent antigen of the vaccinia virus envelope.

J Gordon1, T Kovala, S Dales.   

Abstract

During vaccinia virus (VV) assembly a major polypeptide migrating with an apparent MW of 35K, designated Ag35, is expressed as an early function and becomes an integral component of the lipoprotein envelope surrounding the mature virion. In a previous study evaluating humoral immunity to VV, a prominent response against Ag35 was invariably detected in immunized mice. In the context of our continuing investigations of the structure and function of the vaccinia envelope, with a view to alteration in antigenicity of this agent when used as a vaccine vector for foreign antigens, we carried out detailed mapping of the Ag35 gene, as well as determination of the nucleotide sequence. Use of hybridization-arrested translation, coupled with immunoprecipitation, located this gene within a 2.7-kbp EcoRI fragment of the larger 8.7-kbp HindIII H fragment. By means of S1 endonuclease resistance analysis a viral transcript was identified at the site of the Ag35 gene, where the occurrence of an open reading frame (ORF), corresponding to the transcript, was deduced from DNA sequence determination. However, the ORF encodes a polypeptide of only 22,300 Da predicted MW, which is much lower than the apparent MW estimated from SDS-polyacrylamide gel electrophoresis. The size discrepancy is not due to glycosylation or phosphorylation of Ag35 but may result from a proline-rich sequence which occurs in this polypeptide. To confirm that the ORF recognized in this study does, indeed, encode Ag35, the gene was expressed as a beta-galactosidase fusion protein in pUC19; Escherichia coli transformed with the relevant clones expressed a polypeptide of the appropriate molecular weight and antigenicity, when tested by Western blots. Regarding secondary structure and hydropathicity it can be predicted from the DNA sequence that Ag35 is highly hydrophilic but contains a hydrophobic region at the carboxy terminus, perhaps providing the stretch involved in membrane insertion. Computer search of a bank of protein sequences revealed an unusually strong similarity of 68% between the Ag35 at amino acid positions 44-121 and the G glycoprotein of respiratory syncytial virus at positions 189-264.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462305

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.

Authors:  G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

2.  Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans.

Authors:  W E Demkowicz; J S Maa; M Esteban
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus I3 gene.

Authors:  S C Rochester; P Traktman
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

Authors:  D Huw Davies; Megan M McCausland; Conrad Valdez; Devan Huynh; Jenny E Hernandez; Yunxiang Mu; Siddiqua Hirst; Luis Villarreal; Philip L Felgner; Shane Crotty
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase.

Authors:  G Beaud; R Beaud; D P Leader
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 6.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

7.  Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis.

Authors:  P Traktman; A Caligiuri; S A Jesty; K Liu; U Sankar
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  The pox in the North American backyard: Volepox virus pathogenesis in California mice (Peromyscus californicus).

Authors:  Nadia F Gallardo-Romero; Clifton P Drew; Sonja L Weiss; Maureen G Metcalfe; Yoshinori J Nakazawa; Scott K Smith; Ginny L Emerson; Christina L Hutson; Johanna S Salzer; Jeanine H Bartlett; Victoria A Olson; Cody J Clemmons; Whitni B Davidson; Sherif R Zaki; Kevin L Karem; Inger K Damon; Darin S Carroll
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

9.  Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins.

Authors:  Jennifer D Yoder; Tsefang S Chen; Cliff R Gagnier; Srilakshmi Vemulapalli; Claudia S Maier; Dennis E Hruby
Journal:  Virol J       Date:  2006-03-01       Impact factor: 4.099

10.  A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope.

Authors:  J Gordon; A Mohandas; S Wilton; S Dales
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.